Results 21 to 30 of about 301,002 (287)

Leveraging corona virus disease 2019 vaccination to promote hepatitis C screening

Hepatology Communications, EarlyView., 2022
Abstract Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID‐19) pandemic. However, COVID‐19 vaccination programs also provide an opportunity to engage with a high volume of people in a health care setting.
Aaron Vanderhoff, David Smookler, Mia J. Biondi, Scott Enman, Tintin Fuliang, Sana Mahmood, Agustina Crespi, Maria Marquez, Rafique Van Uum, Lucy You, Brett Wolfson‐Stofko, Renee Logan, Erin LeDrew, Hemant Shah, Harry Janssen, Camelia Capraru, Elisa Venier, Jordan J. Feld   +17 more
wiley   +1 more source

Hepatitis B vaccine birth dose in India: time to reconsider

Human Vaccines & Immunotherapeutics, 2020
Viral hepatitis is increasingly being recognized as a public health problem in India with 96% of all hepatitis mortality attributed to hepatitis B and C combined.
Pragyan Paramita Parija, Mohan Kumar M
doaj   +1 more source

Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.

Journal of Infectious Diseases, 2016
BACKGROUND The duration of protection in children and adults resulting from hepatitis B vaccination is unknown. In 1981, we immunized a cohort of 1578 Alaska Native adults and children from 15 Alaska communities aged ≥6 months using 3 doses of plasma ...
M. Bruce, D. Bruden, D. Hurlburt, C. Zanis, G. Thompson, Lisa Rea, Michele Toomey, Lisa J. Townshend-Bulson, K. Rudolph, L. Bulkow, P. Spradling, R. Baum, T. Hennessy, B. McMahon   +13 more
semanticscholar   +1 more source

Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant

MMWR. Morbidity and mortality weekly report, 2018
Hepatitis B (HepB) vaccination is the primary means of preventing infections and complications caused by hepatitis B virus (HBV). On February 21, 2018, the Advisory Committee on Immunization Practices (ACIP) recommended Heplisav-B (HepB-CpG), a yeast ...
S. Schillie, A. Harris, R. Link-Gelles, J. Romero, J. Ward, Noele P. Nelson   +5 more
semanticscholar   +1 more source

Safety and Preliminary Immunogenicity of Recombinant Hepatitis B (Bio Farma) Vaccine in Adults and Children: A Phase 1 Clinical Trial

Althea Medical Journal, 2023
Background: In order to fulfil the requirements of the national immunization program and sustain the production capacity of the monovalent Hepatitis B vaccine, this study aimed to assess the safety and immunogenicity of the recombinant Hepatitis B ...
Eddy Fadlyana, Rodman Tarigan, Kusnandi Rusmil, Rini Mulia Sari, Cissy B Kartasmita, Behesti Zahra Mardiah, Muhammad Gilang Dwi Putra   +6 more
doaj   +1 more source

Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study

Vaccines, 2023
To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population.
Putri Bungsu Machmud, Amand Führer, Cornelia Gottschick, Rafael Mikolajczyk   +3 more
doaj   +1 more source

Hepatitis B Vaccine and Immunoglobulin: Key Concepts

Journal of Clinical and Translational Hepatology, 2019
Hepatitis B virus (HBV) immunization is safe and has been accepted worldwide as a routine practice. The target of such vaccination is to induce the immune response in the host, resulting in the prevention of replication of HBV.
S. Das, K. Ramakrishnan, S. Behera, Mahalakshmi Ganesapandian, A. S. Xavier, S. Selvarajan   +5 more
semanticscholar   +1 more source

Timing of the First Dose of the Hepatitis B Vaccine in Preterm Infants

Vaccines, 2022
Introduction: The World Health Organization (WHO) recommends all newborn infants receive the first dose of the hepatitis B vaccine within 24 h of birth irrespective of maternal hepatitis B carrier status.
Donna Lei, Taryn Miller, Jeremy Carr, Jim Buttery, Claudia A. Nold-Petry, Marcel F. Nold, Atul Malhotra   +6 more
doaj   +1 more source

Hepatitis B vaccine

Journal of Pediatric Health Care, 1999
Hepatitis B virus (HBV) infection is a health problem that affects numerous infants and children in the United States. Approximately 4000 to 6000 new infections occur each year in children and adolescents; most often they become infected without obvious clinical manifestations. Some persons become chronically infected, and this asymptomatic chronically
Mary Jane Ott, Mary Aruda
openaire   +6 more sources

Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis

Human Vaccines & Immunotherapeutics, 2018
Hepatitis A and B disease burden persists in the US. We assessed hepatitis A and hepatitis B vaccination series completion rates among 350,240 commercial/Medicare and 12,599 Medicaid enrollees aged ≥19 years.
Parinaz K. Ghaswalla, Brandon J. Patterson, Wendy Y. Cheng, Emilie Duchesneau, Monica Macheca, Mei Sheng Duh   +5 more
doaj   +1 more source